Latest / Stock Movers / Novo Nordisk Soars, Johnson & Johnson Drops, ServiceNow Falls
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market.
- 0:13Speaker 1: Harnessing the power of Bloomberg data, take a look at
- 0:17Speaker 1: some of the stocks that are on the move today.
- 0:19Speaker 1: We can do that with Bloomberg's normal nd it nor
- 0:21Speaker 1: what are you looking at?
- 0:22Speaker 2: Well, let's look through one of the biggest stories of
- 0:23Speaker 2: the day. We did see that Novo Nordists want approval
- 0:26Speaker 2: to sell a pill version of its OBCD shot with
- 0:28Speaker 2: GOVI in the United States. So this of course should
- 0:30Speaker 2: help people lose weight or maintain their previous weight loss
- 0:34Speaker 2: over the long term. But this is really an edge
- 0:36Speaker 2: up against Eli Lay, its competitor, because it's essentially giving
- 0:39Speaker 2: it a head start because Eli laly said that its
- 0:42Speaker 2: own oral OBCD drug could be approved by March, so
- 0:45Speaker 2: this is getting in a bit earlier. You're seeing shares
- 0:47Speaker 2: of Novo Nordist take her envy O reflecting that we
- 0:50Speaker 2: see shares up as much as eleven percent, not pairing
- 0:52Speaker 2: up about eight and a half percent. But this is
- 0:54Speaker 2: the biggest jump since January on a single day basis. Yeah,
- 0:58Speaker 2: definitely big news for Nova Nordisk.
- 1:00Speaker 1: Seeing the healthcare space.
- 1:01Speaker 2: Yeah, I'm also looking at shares of Johnson and Johnson.
- 1:03Speaker 2: That's ticker Jay and Jay. We're seeing shares that are
- 1:06Speaker 2: down just a smidge, about six tenths of a percent.
- 1:09Speaker 2: This is after the company was ordered to pay about
- 1:11Speaker 2: one point five six billion dollars to a marilynd woman
- 1:14Speaker 2: who blamed the company's talk based baby powder for causing
- 1:17Speaker 2: her asbestos linked cancer. So we are hearing from researchers
- 1:21Speaker 2: that they have linked asbestos to mesothelioma, and jurors did
- 1:25Speaker 2: find that Jay and Jay and two of its units
- 1:27Speaker 2: and its spinoff Kenview were liable for failing to warn
- 1:30Speaker 2: the woman of its baby powder being tainted with asbestos.
- 1:34Speaker 2: So you are seeing shares citing just a touch off of.
- 1:37Speaker 1: The news Service now little M and a.
- 1:39Speaker 2: Yeah, a little M and A action here on this
- 1:42Speaker 2: What is this Tuesday? Hey, we did see the Service
- 1:45Speaker 2: now This is ticker inow. It reached a deal to
- 1:47Speaker 2: buy the cybersecurity startup Armis. The deal was valued at
- 1:50Speaker 2: about seven point seventy five billion dollars. This is its
- 1:53Speaker 2: largest acquisition to date for the company. So Service Now
- 1:56Speaker 2: will pay in cash for Armis, expects to fund the
- 1:59Speaker 2: transaction combo of cash on hand and debt. They said
- 2:02Speaker 2: that the deal should close in about the second half
- 2:05Speaker 2: of twenty twenty six. We did see shares of the
- 2:07Speaker 2: service now those sliding as much as two point nine
- 2:09Speaker 2: percent earlier. Now it's down about two point three percent
- 2:12Speaker 2: as we speak.
- 2:14Speaker 1: The Stockmovers report from Bloomberg Radio. Check back with us
- 2:18Speaker 1: throughout the day for the latest roundup of companies making
- 2:21Speaker 1: news on Wall Street and for the latest market moving headlines.
- 2:25Speaker 1: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 2:29Speaker 1: dot com, and on Applecarplay and Android Auto with the
- 2:32Speaker 1: Bloomberg Business app.